Immatics N.V. (IMTXW) Financials

IMTXW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 463.1 million 200.8 million
June 30, 2023 446.0 million 208.7 million
March 31, 2023 412.6 million 194.5 million
Dec. 31, 2022 437.7 million 208.9 million

IMTXW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -39.2 million 5.0 million
June 30, 2023 -19.0 million 6.0 million
March 31, 2023 -30.6 million 6.7 million
Dec. 31, 2022 -36.5 million 6.3 million

IMTXW Net Income

No data available :(

IMTXW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 387.5 million - 17.4 million
June 30, 2023 378.0 million - 18.3 million
March 31, 2023 359.5 million - 16.3 million
Dec. 31, 2022 388.7 million - 15.6 million

IMTXW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 88.3 million
June 30, 2023 84.1 million
March 31, 2023 83.6 million
Dec. 31, 2022 73.2 million

IMTXW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 6.9 million 32.3 million 9.4 million -
June 30, 2023 11.8 million 29.7 million 7.4 million -
March 31, 2023 4.7 million 30.1 million 10.4 million -
Dec. 31, 2022 2.8 million 29.9 million 10.5 million -

IMTXW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 6.3 million -
June 30, 2023 24.3 million 29.7 million
March 31, 2023 10.7 million 30.1 million
Dec. 31, 2022 40.4 million 29.9 million

IMTXW

Price: $0.01

52 week price:
0.01
0.03

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 100577

Market Capitalization: 484.4 million

Links: